Citigroup’s DNA X Inc SONM Stock Holding History

Citigroup’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-613	Closed	-$13.5K	–	6306
2025 Q2	$13.5K	Buy	+613	New	+$15.1K	﹤0.01%	5143
2025 Q1	–	Sell	-81	Closed	-$4.61K	–	5934
2024 Q4	$4.61K	Hold	81	–	–	﹤0.01%	5472
2024 Q3	$4.23K	Hold	81	–	–	﹤0.01%	5358
2024 Q2	$14.6K	Hold	81	–	–	﹤0.01%	5075
2024 Q1	$8.91K	Hold	81	–	–	﹤0.01%	5228
2023 Q4	$10.7K	Hold	81	–	–	﹤0.01%	5179
2023 Q3	$9.89K	Hold	81	–	–	﹤0.01%	4546
2023 Q2	$16.8K	Sell	81 -17	-17%	-$3.32K	﹤0.01%	4993
2023 Q1	$17.8K	Hold	98	–	–	﹤0.01%	4547
2022 Q4	$7.48K	Hold	98	–	–	﹤0.01%	4936
2022 Q3	$9K	Sell	98 -96	-49%	-$11.9K	﹤0.01%	5038
2022 Q2	$19K	Sell	194 -24	-11%	-$2.71K	﹤0.01%	5042
2022 Q1	$34K	Buy	218 +135	+163%	+$18.3K	﹤0.01%	4903
2021 Q4	$14K	Buy	+83	New	+$25.2K	﹤0.01%	5494
2020 Q2	–	Hold	0	–	–	–	7660
2020 Q1	–	Sell	-1	Closed	-$4.79K	–	7765
2019 Q4	$7K	Buy	+1	New	+$4.93K	﹤0.01%	7318
2019 Q3	–	Hold	0	–	–	–	7811
2019 Q2	–	Hold	0	–	–	–	7847

Other funds holding SONM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DWM

Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

Citigroup's SONM Position: Q3 2025 in Review

Citigroup sold out of DNA X Inc (SONM) in Q3 2025, closing a stake of 613 shares — an estimated $13.5K sold.

Citigroup first reported a position in SONM in Q4 2019 and held it in 15 quarters. The position peaked at $34K in Q1 2022. 12 funds tracked by Wall St. Rank hold SONM as of Q3 2025.

Citigroup reported no remaining DNA X Inc position as of Q3 2025 after selling out during the quarter.
Citigroup sold 613 DNA X Inc shares in Q3 2025, an estimated $13.5K.
Citigroup first reported a position in DNA X Inc in Q4 2019 and held it in 15 quarters.
Citigroup's DNA X Inc position peaked at $34K in Q1 2022.
12 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.